NCT06256380 Comparing Enhanced Cognitive-behavior Therapy and Family-based Treatment for Adolescents With an Eating Disorder
| NCT ID | NCT06256380 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oslo University Hospital |
| Condition | Feeding and Eating Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-03-07 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-03-07 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this randomized controlled clinical trial is to compare the efficacy of outpatient family-based treatment versus enhanced cognitive behavior therapy for children and adolescents with eating disorders. Because of insufficient recruitment, the study design was modified on December 1st, 2025, to a partially randomized preference design. The main aim is to determine if enhanced cognitive behavior therapy has a similar efficacy as family-based treatment among children and adolescents with eating disorders receiving treatment in an outpatient setting. The main outcome is improvement in eating disorders psychopathology at the end of treatment.
Eligibility Criteria
Inclusion Criteria: 1. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnosed eating disorder 2. Medically stable for outpatient treatment. 3. Living with at least one of their parents 4. At least one of their parents could be actively involved in the treatment 5. Sufficient knowledge in reading, understanding and speaking Norwegian Exclusion Criteria: 1. Avoidant restrictive food intake disorders 2. A co-morbid medical condition or disorder known to influence eating or weight, or influence the possibilities to take part in treatment 3. Psychotic disorders 4. Acute suicidality 5. Substance abuse and/or substance dependence 6. Serious traumatic events in the family making treatment following FBT or CBT-E manual not recommended 7. Unstable psychotropic medication last 6 weeks
Contact & Investigator
Øyvind Rø, MD
PRINCIPAL INVESTIGATOR
Oslo University Hospital
Frequently Asked Questions
Who can join the NCT06256380 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Feeding and Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06256380 currently recruiting?
Yes, NCT06256380 is actively recruiting participants. Contact the research team at ifunderu@ous-hf.no for enrollment information.
Where is the NCT06256380 trial being conducted?
This trial is being conducted at Bergen, Norway, Drammen, Norway, Oslo, Norway, Tromsø, Norway and 1 additional location.
Who is sponsoring the NCT06256380 clinical trial?
NCT06256380 is sponsored by Oslo University Hospital. The principal investigator is Øyvind Rø, MD at Oslo University Hospital. The trial plans to enroll 200 participants.